Kimberly-Clark Corp Stock Price, News & Analysis

Kimberly-Clark (NASDAQ:KMB) announced that its top executives will participate in the Barclays 18th Annual Global Consumer Staples Conference. Chairman and CEO Mike Hsu, President and COO Russ Torres, and CFO Nelson Urdaneta will present on September 3, at 8:15 a.m. ET.

Investors can access the presentation through the Investors section of Kimberly-Clark's website.

Kimberly-Clark (NASDAQ: KMB) has appointed John Carmichael as President of North America, effective September 15th. Carmichael, who joins from Nestlé Canada where he served as President and CEO, will oversee KMB's personal care, family care, and professional businesses across the United States and Canada.

Carmichael brings 30 years of experience from Nestlé, where he demonstrated success in accelerating growth and business transformation. He succeeds interim President Kurt Laufer, who will return to his role as President of U.S. Consumer Sales. In his new position, Carmichael will report to Russ Torres, President and Chief Operating Officer of Kimberly-Clark.

Kimberly-Clark (NASDAQ: KMB) has declared a quarterly dividend of $1.26 per share, payable on October 2, 2025, to stockholders of record as of September 5, 2025. The company has maintained an impressive track record of 91 consecutive years of dividend payments and 53 consecutive years of dividend increases.

The company maintains leading market positions with its portfolio of consumer brands, holding the #1 or #2 position in approximately 70 countries. Kimberly-Clark's products are available in more than 175 countries and territories worldwide.

Kimberly-Clark (Nasdaq: KMB) reported strong Q2 2025 results with net sales of $4.2 billion, showing organic sales growth of 3.9% despite a 1.6% overall decline. The company achieved its highest volume growth in five years at 5.0%, though this was partially offset by pricing investments of 1.2%.

Q2 adjusted EPS was $1.92, down 2.0% year-over-year, while adjusted gross margin decreased 180 basis points to 36.9%. The company raised its 2025 outlook, expecting low-to-mid single digit growth in adjusted operating profit and EPS on a constant-currency basis, with adjusted free cash flow projected at approximately $2 billion.

Kimberly-Clark (NASDAQ: KMB) has scheduled its second quarter 2025 earnings release for August 1, 2025. The company will publish its financial results and supplemental materials at 6:30 a.m. EDT, followed by a live Q&A session with analysts at 8:00 a.m. EDT.

Investors can access the earnings release, supplemental materials, and Q&A session through the company's Investor Relations website. A replay of the webcast will be made available on the same platform after the event.

U by Kotex has partnered with 18-year-old Anna Leigh Waters, the world's #1 pickleball player, to challenge period stigma in sports. Waters, who recently won an undefeated tournament in San Clemente while menstruating, demonstrates that peak performance doesn't pause during periods. The partnership aims to address concerning statistics, including that over 84% of teenage girls aged 11-16 report decreased interest in sports after starting their period, and 25% feel embarrassed to participate in physical activities during menstruation. Research suggests some women may actually experience improved mental agility and faster reaction times during menstruation. The collaboration between U by Kotex and Waters focuses on normalizing period conversations in sports and empowering women to stay active throughout their cycle.

Suzano (SUZ) and Kimberly-Clark announced a major US$3.4 billion joint venture to create a global tissue company operating in over 70 countries. Suzano will acquire a 51% stake for US$1.734 billion, while Kimberly-Clark will retain 49%. The new Netherlands-based company will own 22 manufacturing facilities across 14 countries, with approximately 9,000 employees and an annual production capacity of 1 million tonnes of tissue. The venture includes Kimberly-Clark's international tissue assets, which generated US$3.3 billion in net sales in 2024, and will market iconic brands like Kleenex, Scott, and WypAll. The deal, expected to close in mid-2026, combines Suzano's industrial expertise with Kimberly-Clark's brand management capabilities. Suzano will have majority board control with three of five directors and holds a future call option to acquire Kimberly-Clark's 49% stake.

Kimberly-Clark (KMB) has announced a strategic partnership with Suzano (SUZ) to create a leading international tissue and professional products company. Under the agreement, Suzano will own 51% and KMB will retain 49% of the new venture, which will include KMB's International Family Care and Professional business. The contributed business generated $3.3B in net sales in 2024, with an implied enterprise value of $3.4B. The venture will encompass operations in 70+ countries, 22 manufacturing facilities, and 9,000 employees. The deal will allow KMB to focus on higher-growth personal care segments, with approximately two-thirds of future revenues coming from personal care categories. The transaction is expected to close in mid-2026 and will be $0.30-0.40 dilutive to Adjusted EPS in the first full year. Suzano will have future options to purchase KMB's remaining 49% stake.

Kimberly-Clark (KMB) has awarded 30 Bright Futures college scholarships to high school seniors, children of company employees across North America. The scholarship program, now in its 33rd year, provides grants worth up to $20,000 ($5,000 per school year) for full-time students attending accredited colleges and universities.

This year's scholarship class maintains an impressive average GPA of 3.98, with recipients set to attend prestigious institutions including MIT, Wheaton College, Georgia Tech, and the University of Wisconsin. Since its inception, the Kimberly-Clark Foundation has awarded nearly $50 million in scholarships to more than 2,400 students, with past recipients pursuing careers in medicine, education, armed forces, and engineering.